Berinert 500 unit kits
Ended Awarded Last action
- Contract number
- SPE2DR26FA4A9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,707
Award facts
- Contract value 100% obligated
- $12,707.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $12,707.05, awards Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) a contract to supply 500-unit kits of Berinert, a specialized pharmaceutical product used for treating hereditary angioedema. The award was made without a set-aside designation through competitive procedures by the Defense Logistics Agency (DLA), with performance scheduled for completion by February 20, 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and holds a significant $999.9 billion Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX) running through December 2026, which serves as the underlying contract vehicle enabling this delivery order.
The DLA's Medical Supply Chain relies on Amerisourcebergen Drug Corp as a prime pharmaceutical vendor to support military healthcare systems and related federal medical institutions globally. This delivery order exemplifies the company's extensive portfolio of pharmaceutical supply contracts, which encompass brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The firm fixed-price contract structure reflects the standardized procurement approach used for federal pharmaceutical acquisitions, ensuring predictable costs for critical medical supplies required by the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FA4A9?
SPE2DR26FA4A9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FA4A9 worth?
The government has obligated $12,707 on SPE2DR26FA4A9.
Is contract SPE2DR26FA4A9 an order under another contract?
Yes. SPE2DR26FA4A9 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA4A9 competed?
The extent of competition for SPE2DR26FA4A9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award